chr17-80050251-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_017950.4(CCDC40):​c.1127C>G​(p.Thr376Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 1,585,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T376T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.11

Publications

0 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15171096).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC40NM_017950.4 linkc.1127C>G p.Thr376Ser missense_variant Exon 7 of 20 ENST00000397545.9 NP_060420.2
CCDC40NM_001243342.2 linkc.1127C>G p.Thr376Ser missense_variant Exon 7 of 18 NP_001230271.1
CCDC40NM_001330508.2 linkc.1127C>G p.Thr376Ser missense_variant Exon 7 of 11 NP_001317437.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkc.1127C>G p.Thr376Ser missense_variant Exon 7 of 20 5 NM_017950.4 ENSP00000380679.4

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152190
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000562
AC:
11
AN:
195568
AF XY:
0.0000468
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000119
Gnomad OTH exome
AF:
0.000198
GnomAD4 exome
AF:
0.000237
AC:
339
AN:
1432942
Hom.:
0
Cov.:
34
AF XY:
0.000222
AC XY:
158
AN XY:
710846
show subpopulations
African (AFR)
AF:
0.0000306
AC:
1
AN:
32658
American (AMR)
AF:
0.00
AC:
0
AN:
40078
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38008
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83180
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50466
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4150
European-Non Finnish (NFE)
AF:
0.000306
AC:
336
AN:
1099556
Other (OTH)
AF:
0.0000338
AC:
2
AN:
59210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152190
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41438
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.0000529
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000239
AC:
2
ExAC
AF:
0.0000421
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:2
Jan 21, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1127C>G (p.T376S) alteration is located in exon 7 (coding exon 7) of the CCDC40 gene. This alteration results from a C to G substitution at nucleotide position 1127, causing the threonine (T) at amino acid position 376 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Jan 07, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 376 of the CCDC40 protein (p.Thr376Ser). This variant is present in population databases (rs372392201, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CCDC40-related conditions. ClinVar contains an entry for this variant (Variation ID: 407775). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
18
DANN
Benign
0.77
DEOGEN2
Benign
0.11
.;T;.;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.33
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.65
T;T;T;T
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.15
T;T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Uncertain
2.7
M;M;M;M
PhyloP100
1.1
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.5
N;N;N;N
REVEL
Benign
0.062
Sift
Benign
0.16
T;D;T;D
Sift4G
Benign
0.34
T;T;T;T
Polyphen
0.18, 0.99
.;B;.;D
Vest4
0.29
MutPred
0.23
Gain of MoRF binding (P = 0.11);Gain of MoRF binding (P = 0.11);Gain of MoRF binding (P = 0.11);Gain of MoRF binding (P = 0.11);
MVP
0.26
MPC
0.18
ClinPred
0.10
T
GERP RS
4.7
Varity_R
0.15
gMVP
0.083
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372392201; hg19: chr17-78024050; API